Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
393
datasets available to search
ShareScore release 0.9.0
Dataset results
393 results for “mRNA vaccine”
Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People
ClinicalTrials.gov study NCT05352867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Booster Effect of mRNA Vaccine on Antibody Response for SARS-CoV-2 After Complete Vaccination With Sinos
ClinicalTrials.gov study NCT05213455. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
ClinicalTrials.gov study NCT06928922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older
ClinicalTrials.gov study NCT05812014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels
ClinicalTrials.gov study NCT04923386. IPD Sharing: NO. Countries: 1. Publications: 0.
Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps
ClinicalTrials.gov study NCT04928456. IPD Sharing: NO. Countries: 1. Publications: 0.
A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19
ClinicalTrials.gov study NCT05682638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China
ClinicalTrials.gov study NCT05547256. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine
ClinicalTrials.gov study NCT05492643. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms
ClinicalTrials.gov study NCT06026800. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evi
ClinicalTrials.gov study NCT04144348. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age
ClinicalTrials.gov study NCT06694389. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
ClinicalTrials.gov study NCT06585241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors
ClinicalTrials.gov study NCT06195384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
ClinicalTrials.gov study NCT06680128. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age
ClinicalTrials.gov study NCT05575492. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core)
ClinicalTrials.gov study NCT05001373. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study
ClinicalTrials.gov study NCT05572658. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
ClinicalTrials.gov study NCT05939648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy
ClinicalTrials.gov study NCT04163094. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.